Signa Sa De Cv, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PIRFENIDONE EP, with a corresponding US DMF Number 15168.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 13, 2018, and payment made on May 25, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II